Copilot
Your everyday AI companion
About 334,000 results
  1. Semaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with Type 2 diabetes and chronic kidney disease in a major clinical trial, the results of which were published on Friday.
    www.nytimes.com/2024/05/24/well/ozempic-kidney-disease-semaglutide.html
    www.nytimes.com/2024/05/24/well/ozempic-kidney-disease-semaglutide.html
    Was this helpful?
  2. People also ask
  3. Effects of Semaglutide on Chronic Kidney Disease in Patients with …

  4. Ozempic reduces risk of serious illness and death in people with

  5. Ozempic and Wegovy Slash Kidney Disease Risks in People With …

  6. Ozempic May Help Cut Death Risk From Diabetes, Kidney Disease

  7. Ozempic Lowers Odds for Death, Illness in People With Kidney …

  8. Novo Nordisk's Ozempic cuts risk of kidney disease progression

  9. Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

  10. Effects of once-weekly subcutaneous semaglutide on …

    WEBSep 21, 2020 · A meta-analysis of randomised controlled trials investigating the effects of RAAS inhibition and other interventions on albuminuria has shown that reductions in UACR are associated with …

  11. Ozempic Slows Kidney Disease, Cuts Cardiorenal Death Risk in